Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

about

Quantification of Dialytic Removal and Extracellular Calcium Mass Balance during a Weekly Cycle of Hemodialysis.Second Chances to Improve ESRD Outcomes With a Second-Generation Calcimimetic.

P2860

Q35988171-42DF7FF9-96B4-44F4-A731-B482D0D059DE Q40996542-4B7F8CEF-3B6D-4231-B98B-CBA782B259EC

P2860

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

Item

http://www.wikidata.org/entity/Q36900943

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cinacalcet, dialysate calcium ...... ar events in the EVOLVE trial.

@en

type

Item

label

Cinacalcet, dialysate calcium ...... ar events in the EVOLVE trial.

@en

prefLabel

Cinacalcet, dialysate calcium ...... ar events in the EVOLVE trial.

@en

P1476

Cinacalcet, dialysate calcium ...... ar events in the EVOLVE trial.

@en

P2093

Bastian Dehmel

http://www.w3.org/2001/XMLSchema#string

Charles A Herzog

http://www.w3.org/2001/XMLSchema#string

David C Wheeler

http://www.w3.org/2001/XMLSchema#string

Geoffrey A Block

http://www.w3.org/2001/XMLSchema#string

Gerard M London

http://www.w3.org/2001/XMLSchema#string

Glenn M Chertow

http://www.w3.org/2001/XMLSchema#string

John P Middleton

http://www.w3.org/2001/XMLSchema#string

Jürgen Floege

http://www.w3.org/2001/XMLSchema#string

Patrick H Pun

http://www.w3.org/2001/XMLSchema#string

Patrick S Parfrey

http://www.w3.org/2001/XMLSchema#string

P2860

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiolo

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia.

Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients.

Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration.

KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study.

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview.

P304

421-431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HDI.12382

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kenneth W Mahaffey

P577

2015-11-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26564024

http://www.w3.org/2001/XMLSchema#string

P932

4866914

http://www.w3.org/2001/XMLSchema#string

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

about

P2860

P2860

Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trial.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932